Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-016481
Filing Date
2025-04-03
Accepted
2025-04-03 16:06:02
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1743710748.html 4  
1 FORM 4 wk-form4_1743710748.xml 4 3942
  Complete submission text file 0001628280-25-016481.txt   5462
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROMIS NEUROSCIENCES INC. SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address
Mandel-Brehm Josh (Reporting) CIK: 0001927058 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42365 | Film No.: 25809385